<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39430717</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Influencing Canadian young adults to receive additional COVID-19 vaccination shots: the efficacy of brief video interventions focusing on altruism and individualism.</ArticleTitle><Pagination><StartPage>1414345</StartPage><MedlinePgn>1414345</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1414345</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2024.1414345</ELocationID><Abstract><AbstractText>Younger adults, aged 18-39 years, exhibit low COVID-19 additional vaccine (i.e., vaccination beyond the original 2-dose series) uptake recommended in Canada. No study has examined how altruistic and individualistic messaging can influence COVID-19 additional dose intentions. The present study aimed to estimate the efficacy of altruism and individualism-based videos on vaccine intentions and to explore the multivariable associations between vaccine related individual psychosocial factors and intention to receive the COVID-19 vaccine. Using a web-based survey in a three-arm, pre-post randomized control trial design, we recruited Canadians aged 18-39 years in both English and French. Participants were randomly allocated in a 1:1:1 ratio to receive the active control (COVID-19 general information), control + altruism or control + altruism + individualism. The video interventions were developed with a media company, based on results of a focus group study conducted previously. The measurement of COVID-19 additional dosage intentions before and after completing the interventions was informed by the multistage Precaution Adoption Process Model. The McNemar Chi-square was used to evaluate within-group changes, and the Pearson Chi-square test was used to evaluate between-group changes post-intervention. The measurement of various psychosocial factors was informed by use of validated scale and self-report questions. We employed a generalized Structural Equation Model to evaluate the associations between COVID-19 vaccine intentions and the psychosocial factors. Analyses were performed on 3,431 participants (control: <i>n</i> = 1,149, control + altruism: <i>n</i> = 1,142, control + altruism + individualism: <i>n</i> = 1,140). Within-group results showed that participants transitioned significantly in all three groups in the direction of higher intentions for receiving additional COVID-19 vaccine doses. The between-group differences in post intervention vaccine intentions were not significant. We found that psychosocial factors that include, collectivism, intellectual humility, intolerance to uncertainty, religiosity, identifying as gender diverse, and being indigenous were associated with higher vaccine intentions, whereas pandemic fatigue was associated with lower vaccine intentions. Our study highlighted that a short video that includes altruism and individualism messaging or general COVID-19 information can increase intentions to vaccine among young adults. Furthermore, we gained a comprehensive understanding of various psychosocial factors that influence ongoing COVID-19 vaccination. Our findings can be used to influence public health messaging around COVID-19 vaccination.</AbstractText><CopyrightInformation>Copyright © 2024 Batra, Tatar, Zhu, Perez, Haward, Zimet and Rosberger.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batra</LastName><ForeName>Rachita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Lady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatar</LastName><ForeName>Ovidiu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Lady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Lady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Samara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Institute, McGill University Health Centre and Psychosocial Oncology Program, Division of Supportive and Palliative Care, Cedars Cancer Centre, McGill University Health Centre, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haward</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Lady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimet</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine, Indiana University, Indianapolis, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosberger</LastName><ForeName>Zeev</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Lady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000533" MajorTopicYN="Y">Altruism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033182" MajorTopicYN="Y">Intention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014741" MajorTopicYN="N">Video Recording</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">altruism</Keyword><Keyword MajorTopicYN="N">individualism</Keyword><Keyword MajorTopicYN="N">mRNA vaccines</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword><Keyword MajorTopicYN="N">vaccine intentions</Keyword><Keyword MajorTopicYN="N">video intervention</Keyword><Keyword MajorTopicYN="N">young adults</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39430717</ArticleId><ArticleId IdType="pmc">PMC11488519</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2024.1414345</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Ten threats to global health in 2019. (2019). Available at:
https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (Accessed October 9, 2020).</Citation></Reference><Reference><Citation>Craig M. Lives saved by COVID-19 vaccines. J Paediatr Child Health. (2022) 58:2129. doi: 10.1111/jpc.16213</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.16213</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada . Canadian COVID-19 vaccination coverage report. (2023). Available at:
https://health-infobase.canada.ca/covid-19/vaccination-coverage/archive/2023-01-02/index.html (Accessed October 4, 2023).</Citation></Reference><Reference><Citation>Pelley L. Just 15% of Canadians got updated COVID vaccines this fall, new figures show. CBC News. (2023)</Citation></Reference><Reference><Citation>Government of Canada . COVID-19 vaccines: Canadian Immunization GuidE. (2023). Available at:
https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-26-covid-19-vaccine.html#shr-pg0 (Accessed March 15, 2023).</Citation></Reference><Reference><Citation>Andrews N, Stowe J, Kirsebom F, Toffa S, Sachdeva R, Gower C, et al. . Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. (2022) 28:831–7. doi: 10.1038/s41591-022-01699-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01699-1</ArticleId><ArticleId IdType="pmc">PMC9018410</ArticleId><ArticleId IdType="pubmed">35045566</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt D. SARS-CoV-2: from herd immunity to hybrid immunity. Nat Rev Immunol. (2022) 22:333–4. doi: 10.1038/s41577-022-00725-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00725-0</ArticleId><ArticleId IdType="pmc">PMC9016684</ArticleId><ArticleId IdType="pubmed">35440758</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenchula S, Karunakaran P, Sharma S, Chavan M. Current evidence on efficacy of COVID-19 booster dose vaccination against the omicron variant: a systematic review. J Med Virol. (2022) 94:2969–76. doi: 10.1002/jmv.27697, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27697</ArticleId><ArticleId IdType="pmc">PMC9088621</ArticleId><ArticleId IdType="pubmed">35246846</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada . Vaccines for COVID-19: how to get vaccinated. (2023).</Citation></Reference><Reference><Citation>Limbu YB, Huhmann BA. Why some people are hesitant to receive COVID-19 boosters: a systematic review. Trop Med Infect Dis. (2023) 8:159. doi: 10.3390/tropicalmed8030159, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed8030159</ArticleId><ArticleId IdType="pmc">PMC10054177</ArticleId><ArticleId IdType="pubmed">36977160</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada . Highlights from the 2022–2023 seasonal influenza (Flu) vaccination coverage survey. (2022-2023).</Citation></Reference><Reference><Citation>Eberhardt J, Ling J. Explaining COVID-19 vaccination intention in younger adults using protection motivation theory. Health Psychol. (2023) 42:577–83. doi: 10.1037/hea0001231, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/hea0001231</ArticleId><ArticleId IdType="pubmed">35980723</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Cheng Y, Sui M. The moderating effects of perceived severity on the generational gap in preventive behaviors during the COVID-19 pandemic in the U.S. Int J Environ Res Public Health. (2021) 18. doi: 10.3390/ijerph18042011</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042011</ArticleId><ArticleId IdType="pmc">PMC7922035</ArticleId><ArticleId IdType="pubmed">33669713</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Report of the SAGE working group on vaccine hesitancy. (2014).</Citation></Reference><Reference><Citation>Pfattheicher S, Petersen MB, Böhm R. Information about herd immunity through vaccination and empathy promote COVID-19 vaccination intentions. Health Psychol. (2022) 41:85–93. doi: 10.1037/hea0001096, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/hea0001096</ArticleId><ArticleId IdType="pubmed">34570535</ArticleId></ArticleIdList></Reference><Reference><Citation>James EK, Bokemper SE, Gerber AS, Omer SB, Huber GA. Persuasive messaging to increase COVID-19 vaccine uptake intentions. Vaccine. (2021) 39:7158–65. doi: 10.1016/j.vaccine.2021.10.039, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8531257</ArticleId><ArticleId IdType="pubmed">34774363</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C, Bhogal MS, Byrne A. The role of altruism vs self-interest in COVID-19 vaccination uptake in the United Kingdom. Public Health. (2022) 213:91–3. doi: 10.1016/j.puhe.2022.10.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9575617</ArticleId><ArticleId IdType="pubmed">36399867</ArticleId></ArticleIdList></Reference><Reference><Citation>Léger C, Deslauriers F, Gosselin Boucher V, Phillips M, Bacon SL, Lavoie KL. Prevalence and motivators of getting a COVID-19 booster vaccine in Canada: results from the iCARE study. Vaccine. (2023) 11. doi: 10.3390/vaccines11020291, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020291</ArticleId><ArticleId IdType="pmc">PMC9960725</ArticleId><ArticleId IdType="pubmed">36851169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P, Tatar O, Griffin-Mathieu G, Perez S, Haward B, Zimet G, et al. . The efficacy of a brief, altruism-eliciting video intervention in enhancing COVID-19 vaccination intentions among a population-based sample of younger adults: randomized controlled trial. JMIR Public Health Surveill. (2022) 8:e37328. doi: 10.2196/37328, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37328</ArticleId><ArticleId IdType="pmc">PMC9153910</ArticleId><ArticleId IdType="pubmed">35544437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P, Tatar O, Haward B, Steck V, Griffin-Mathieu G, Perez S, et al. . Examining an altruism-eliciting video intervention to increase COVID-19 vaccine intentions in younger adults: a qualitative assessment using the realistic evaluation framework. Vaccine. (2023) 11. doi: 10.3390/vaccines11030628, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030628</ArticleId><ArticleId IdType="pmc">PMC10056235</ArticleId><ArticleId IdType="pubmed">36992212</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman D, Loe BS, Yu LM, Freeman J, Chadwick A, Vaccari C, et al. . Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial. Lancet Public Health. (2021) 6:e416–27. doi: 10.1016/s2468-2667(21)00096-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-2667(21)00096-7</ArticleId><ArticleId IdType="pmc">PMC8116130</ArticleId><ArticleId IdType="pubmed">33991482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Chu H. Vaccine for yourself, your community, or your country? Examining audiences' response to distance framing of COVID-19 vaccine messages. Patient Educ Couns. (2022) 105:284–9. doi: 10.1016/j.pec.2021.08.019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2021.08.019</ArticleId><ArticleId IdType="pmc">PMC8384529</ArticleId><ArticleId IdType="pubmed">34479746</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadas E, Bruvold NT, Nelson MR. A reduced version of the horizontal and vertical individualism and collectivism scale: a four-country assessment. J Bus Res. (2008) 61:201–10. doi: 10.1016/j.jbusres.2007.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbusres.2007.06.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumeister R, Vohs K. Encyclopedia of social psychology. Thousand Oaks, CA: SAGE Publications, Inc.</Citation></Reference><Reference><Citation>Banker CC, Leary MR. Hypo-egoic nonentitlement as a feature of humility. Personal Soc Psychol Bull. (2020) 46:738–53. doi: 10.1177/0146167219875144, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0146167219875144</ArticleId><ArticleId IdType="pubmed">31538849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen NO, Knäuper B, Sammut J. Do individual differences in intolerance of uncertainty affect health monitoring? Psychol Health. (2007) 22:413–30. doi: 10.1080/14768320600941038</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14768320600941038</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Deng J, Du M, Liu Q, Wang Y, Yan W, et al. . Pandemic fatigue and vaccine hesitancy among people who have recovered from COVID-19 infection in the post-pandemic era: cross-sectional study in China. Vaccines. (2023) 11. doi: 10.3390/vaccines11101570, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11101570</ArticleId><ArticleId IdType="pmc">PMC10610579</ArticleId><ArticleId IdType="pubmed">37896973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S. The CONSORT statement. Saudi J Anaesth. (2019) 13:27–s30. doi: 10.4103/sja.SJA_559_18, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sja.SJA_559_18</ArticleId><ArticleId IdType="pmc">PMC6398298</ArticleId><ArticleId IdType="pubmed">30930716</ArticleId></ArticleIdList></Reference><Reference><Citation>National Advisory Committee on immunization (NACI). COVID-19 vaccines: Canadian immunization guide. Government of Canada (2023).</Citation></Reference><Reference><Citation>Weinstein ND, Sandman PM, Blalock SJ. The precaution adoption process model. Wiley Encyclopedia Health Psychol. (2020):495–506. doi: 10.1002/9781119057840.ch100</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781119057840.ch100</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. (2022) 22:1293–302. doi: 10.1016/s1473-3099(22)00320-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(22)00320-6</ArticleId><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada . Reported side effects following COVID-19 vaccination in Canada. (2024).</Citation></Reference><Reference><Citation>Canadian Institutes of Health Information . Wait times for priority procedures in Canada. (2022).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . COVID data tracker. (2024). Available at:
https://covid.cdc.gov/covid-data-tracker/#datatracker-home [Accessed January 5, 2022)</Citation></Reference><Reference><Citation>Spreng RN, McKinnon MC, Mar RA, Levine B. The Toronto empathy questionnaire: scale development and initial validation of a factor-analytic solution to multiple empathy measures. J Pers Assess. (2009) 91:62–71. doi: 10.1080/00223890802484381, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00223890802484381</ArticleId><ArticleId IdType="pmc">PMC2775495</ArticleId><ArticleId IdType="pubmed">19085285</ArticleId></ArticleIdList></Reference><Reference><Citation>Drążkowski D, Trepanowski R, Fointiat V. Vaccinating to protect others: the role of self-persuasion and empathy among young adults. Vaccines. (2022) 10. doi: 10.3390/vaccines10040553, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040553</ArticleId><ArticleId IdType="pmc">PMC9029351</ArticleId><ArticleId IdType="pubmed">35455302</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonhardt JM, Pezzuti T. Vaccination acceptance across cultures: the roles of collectivism, empathy, and homophily. J Int Mark. (2021) 30:13–27. doi: 10.1177/1069031X211073179</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1069031X211073179</ArticleId></ArticleIdList></Reference><Reference><Citation>Carleton RN, Norton MAPJ, Asmundson GJG. Fearing the unknown: a short version of the intolerance of uncertainty scale. J Anxiety Disord. (2007) 21:105–17. doi: 10.1016/j.janxdis.2006.03.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janxdis.2006.03.014</ArticleId><ArticleId IdType="pubmed">16647833</ArticleId></ArticleIdList></Reference><Reference><Citation>Shacham M, Hamama-Raz Y, Ben-Ezra M, Levin Y. Association between COVID-19 and seasonal influenza vaccines to vaccine hesitancy, intolerance of uncertainty and mental health. Vaccine. (2023) 11:403. doi: 10.3390/vaccines11020403, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020403</ArticleId><ArticleId IdType="pmc">PMC9959542</ArticleId><ArticleId IdType="pubmed">36851278</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Blazquez C, Romay-Barja M, Falcon M, Ayala A, Forjaz MJ. Psychometric properties of the COVID-19 pandemic fatigue scale: cross-sectional online survey study. JMIR Public Health Surveill. (2022) 8:e34675. doi: 10.2196/34675, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/34675</ArticleId><ArticleId IdType="pmc">PMC9501671</ArticleId><ArticleId IdType="pubmed">35785547</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumrei-Mancuso EJ, Rouse SV. The development and validation of the comprehensive intellectual humility scale. J Pers Assess. (2016) 98:209–21. doi: 10.1080/00223891.2015.1068174, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00223891.2015.1068174</ArticleId><ArticleId IdType="pubmed">26542408</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh HP, Senger AR. A little shot of humility: intellectual humility predicts vaccination attitudes and intention to vaccinate against COVID-19. J Appl Soc Psychol. (2021) 51:449–60. doi: 10.1111/jasp.12747, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jasp.12747</ArticleId><ArticleId IdType="pmc">PMC8014467</ArticleId><ArticleId IdType="pubmed">33821032</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds WM. Development of reliable and valid short of the Marlowe-Crowne social desirability. J Clin Psychol. (1982) 38:119–25. doi: 10.1002/1097-4679(198201)38:1&lt;119:AID-JCLP2270380118&gt;3.0.CO;2-I</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4679(198201)38:1&lt;119:AID-JCLP2270380118&gt;3.0.CO;2-I</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. (2009) 1:51–4. PMID:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256489</ArticleId><ArticleId IdType="pubmed">22263004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangiafico S, Mangiafico S. Package ‘rcompanion’. (2024). Available at:
https://cran.r-project.org/web/packages/rcompanion/rcompanion.pdf (Accessed February 17, 2024).</Citation></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. (1995) 57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp . Stata structural equation modelling reference manual. Release 13. College Station, TX: Stata Press Publication; (2013).</Citation></Reference><Reference><Citation>Witus LS, Larson E. A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention. PLoS One. (2022) 17:e0267580. doi: 10.1371/journal.pone.0267580, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267580</ArticleId><ArticleId IdType="pmc">PMC9119500</ArticleId><ArticleId IdType="pubmed">35587462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. Attitudes toward COVID-19 vaccines and vaccine uptake intent in China: the role of collectivism, interpersonal communication, and the use of news and information websites. Curr Res Ecol Soc Psychol. (2022) 3:100065. doi: 10.1016/j.cresp.2022.100065, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cresp.2022.100065</ArticleId><ArticleId IdType="pmc">PMC9484136</ArticleId><ArticleId IdType="pubmed">36158998</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Wang Y. Is empathy associated with more prosocial behaviour? A meta-analysis. Asian J Soc Psychol. (2023) 26:3–22. doi: 10.1111/ajsp.12537</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajsp.12537</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleksy T, Wnuk A, Gambin M, Łyś A, Bargiel-Matusiewicz K, Pisula E. Barriers and facilitators of willingness to vaccinate against COVID-19: role of prosociality, authoritarianism and conspiracy mentality. A four-wave longitudinal study. Pers Individ Dif. (2022) 190:111524. doi: 10.1016/j.paid.2022.111524, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.paid.2022.111524</ArticleId><ArticleId IdType="pmc">PMC8767760</ArticleId><ArticleId IdType="pubmed">35068638</ArticleId></ArticleIdList></Reference><Reference><Citation>Plohl N, Musil B. Assessing the incremental value of intellectual humility and cognitive reflection in predicting trust in science. Personal Individ Differ. (2023) 214:112340. doi: 10.1016/j.paid.2023.112340</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.paid.2023.112340</ArticleId></ArticleIdList></Reference><Reference><Citation>Haktanir A, Can N, Seki T, Kurnaz MF, Dilmac B. Do we experience pandemic fatigue? Current state, predictors, and prevention. Curr Psychol. (2022) 41:7314–25. doi: 10.1007/s12144-021-02397-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12144-021-02397-w</ArticleId><ArticleId IdType="pmc">PMC8527300</ArticleId><ArticleId IdType="pubmed">34690475</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Pandemic fatigue -reinvigorating the public to prevent COVID-19. (2020).</Citation></Reference><Reference><Citation>Health Canada . Government of Canada highlights budget investments to strengthen public health care and support health workers. (2023). Available at:
https://www.canada.ca/en/health-canada/news/2023/04/government-of-canada-highlights-budget-investments-to-strengthen-public-health-care-and-support-health-workers.html.</Citation></Reference><Reference><Citation>Nova Scotia Health . New investments support caregivers in long-term care facilities, at home. (2022). Available at: https://news.novascotia.ca/en/2022/12/08/new-investments-support-caregivers-long-term-care-facilities-home#:~:text=Investments%20to%20support%20caregivers%3A,for%20infection%20control%20in%20facilities.</Citation></Reference><Reference><Citation>Public Health Agency of Canada . Government of Canada invests in projects to reduce risks of dementia and to support people living with dementia and caregivers. (2024).</Citation></Reference><Reference><Citation>Lau BHP, Yuen SWH, Yue RPH, Grépin KA. Understanding the societal factors of vaccine acceptance and hesitancy: evidence from Hong Kong. Public Health. (2022) 207:39–45. doi: 10.1016/j.puhe.2022.03.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2022.03.013</ArticleId><ArticleId IdType="pmc">PMC9040517</ArticleId><ArticleId IdType="pubmed">35486982</ArticleId></ArticleIdList></Reference><Reference><Citation>Graupensperger S, Abdallah DA, Lee CM. Social norms and vaccine uptake: college students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine. Vaccine. (2021) 39:2060–7. doi: 10.1016/j.vaccine.2021.03.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.03.018</ArticleId><ArticleId IdType="pmc">PMC7965606</ArticleId><ArticleId IdType="pubmed">33741191</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson K, Vartanova I. Vaccine confidence is higher in more religious countries. Hum Vaccin Immunother. (2022) 18:1–3. doi: 10.1080/21645515.2021.1883389, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1883389</ArticleId><ArticleId IdType="pmc">PMC8920254</ArticleId><ArticleId IdType="pubmed">33705261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. (1991) 50:179–211. doi: 10.1016/0749-5978(91)90020-t</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0749-5978(91)90020-t</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyda A, King C, Dey A, Leask J, Dunn AG. A systematic review of studies that measure parental vaccine attitudes and beliefs in childhood vaccination. BMC Public Health. (2020) 20:1253. doi: 10.1186/s12889-020-09327-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09327-8</ArticleId><ArticleId IdType="pmc">PMC7433363</ArticleId><ArticleId IdType="pubmed">32807124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>